2020
DOI: 10.1155/2020/2938236
|View full text |Cite
|
Sign up to set email alerts
|

Late Metastatic Melanoma after 25 Years: A Case Report and a Brief Literature Review

Abstract: The incidence of cutaneous malignant melanoma has shown a drastic increase over recent decades, and approximately 70% of newly diagnosed melanoma are tumors with a Breslow thickness less or equal to 1 mm. In the literature, there are well-documented rare cases of late metastasis of thin melanoma, and given their growing incidence, it is expected in the future to see more cases of late recurrence. We present a case report of a metastatic cutaneous melanoma 25 years from diagnosis and a review of the literature.… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 52 publications
0
1
0
Order By: Relevance
“…Generally, patients with a diagnosis of early melanoma are considered cured and discharged from close follow-up after 5–10 years. However, up to 6.9% of melanoma patients experience recurrence even 10 years after initial diagnosis [79,80]. This event is defined as ‘late recurrence’ and could be explained by ‘tumor dormancy’: cancer cells persist below the threshold of diagnostic detection for months to decades.…”
Section: Risk Of Disease Progression or Recurrence In Melanoma Patientsmentioning
confidence: 99%
“…Generally, patients with a diagnosis of early melanoma are considered cured and discharged from close follow-up after 5–10 years. However, up to 6.9% of melanoma patients experience recurrence even 10 years after initial diagnosis [79,80]. This event is defined as ‘late recurrence’ and could be explained by ‘tumor dormancy’: cancer cells persist below the threshold of diagnostic detection for months to decades.…”
Section: Risk Of Disease Progression or Recurrence In Melanoma Patientsmentioning
confidence: 99%